{"organizations": [], "uuid": "da8a429a7db600a282fc886bad4dbc666b5f0caf", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180131.html", "section_title": "Archive News &amp; Video for Wednesday, 31 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-a1m-pharma-applies-for-clinical-ph/brief-a1m-pharma-applies-for-clinical-phase-i-study-idUSFWN1PQ0ZJ", "country": "US", "domain_rank": 408, "title": "BRIEF-A1M Pharma Applies For Clinical Phase I Study", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 1.0, "site_type": "news", "published": "2018-01-31T21:04:00.000+02:00", "replies_count": 0, "uuid": "da8a429a7db600a282fc886bad4dbc666b5f0caf"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-a1m-pharma-applies-for-clinical-ph/brief-a1m-pharma-applies-for-clinical-phase-i-study-idUSFWN1PQ0ZJ", "ord_in_thread": 0, "title": "BRIEF-A1M Pharma Applies For Clinical Phase I Study", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 31 (Reuters) - A1M PHARMA AB:\n* A1M PHARMA SUBMITS APPLICATION TO THE SWEDISH MEDICAL PRODUCTS AGENCY TO CONDUCT CLINICAL PHASE I STUDY WITH ROSGARDâ„¢ Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-31T21:04:00.000+02:00", "crawled": "2018-02-01T15:06:47.024+02:00", "highlightTitle": ""}